Progenics Pharmaceuticals, Inc. announced that Dr. Paul Maddon, the founder of the company, having served on the company’s Board of Directors for three decades, will serve out his current term as director and retire from the Board as of the company’s 2016 Annual Meeting of Stockholders on June 8. The company also announced that Mr. Bradley Campbell, President and Chief Operating Officer of Amicus Therapeutics, Inc., has been nominated for election to the Board of Directors of the company at the upcoming annual meeting of stockholders.